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Depression, a complex mood disorder, displays high comorbidity with anxiety and cognitive 
disorders. To establish the extent of inter-dependence between these behavioral domains, 
we here undertook a systematic analysis to establish interactions between mood [assessed 
with the forced-swimming (FST) and sucrose consumption tests (SCT)], anxiety [elevated-
plus maze (EPM) and novelty suppressed feeding (NSF) tests] and cognition (spatial memory 
and behavioral ﬂ  exibility tests) in rats exposed to unpredictable chronic-mild-stress (uCMS). 
Expectedly, uCMS induced depressive-like behavior, a hyperanxious phenotype and cognitive 
impairment; with the exception of the measure of anxiety in the EPM, these effects were 
attenuated by antidepressants (imipramine, ﬂ  uoxetine). Measures of mood by the FST and 
SCT were strongly correlated, whereas no signiﬁ  cant correlations were found between the 
different measures of anxiety (EPM and NSF); likewise, measures of cognition by spatial 
memory and behavioral ﬂ  exibility tests were poorly correlated. Inter-domain analysis revealed 
signiﬁ  cant correlations between mood (FST and SCT) and anxiety-like behavior (NSF , but not 
EPM). Furthermore, signiﬁ  cant correlations were found between cognitive performance 
(reverse learning task) and mood (FST and SCT) and anxiety-like behavior (NSF). These results 
demonstrate interactions between different behavioral domains that crosscut the disciplines 
of psychiatry and neurology.
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purposes and for their modelling, tends to hinder understanding 
of the individual and synergistic contributions of these dimensions 
to the overall features of the clinical disorder.
Animal models to study the etiopathogenic factors involved in 
depression and which are aimed at facilitating novel therapeutic 
strategies usually consider the disease from a monosymptomatic 
perspective. Each of the available models usually relies on a sin-
gle behavioral phenotype that is theoretically related to a core 
depressive symptom (face validity) and which can be modulated 
by psychotropic drugs with antidepressive properties (predictive 
validity) (Fuchs and Flïugge, 2006; Kalueff et al., 2007). Despair 
paradigms such as the forced swimming (Cryan et al., 2005b) and 
tail suspension (Cryan et al., 2005a) tests are commonly used for 
verifying the potential efﬁ  cacy of acutely and chronically admin-
istered antidepressants. These tests, which examine reversibility of 
the learned helplessness response that develops upon exposure to 
an inescapable stress, have, however, a serious ﬂ  aw: drug efﬁ  cacy is 
measured under basal conditions, i.e. in animals that do not neces-
sarily  display signs of depressive-like behavior, which seriously com-
promises their clinical therapeutic relevance (Cryan and Slattery, 
2007). Models that somewhat overcome the problem of aetiologi-
cal validity, include exposure to a paradigm in which the animal 
repeatedly fails to escape from an inescapable shock (learned help-
lessness) (Henn and Vollmayr, 2005), olfactory bulbectomy (Song 
and Leonard, 2005), and chronic exposure to stressors of variable 
INTRODUCTION
Psychiatric disorders, including depression, are complex and het-
erogeneous clinical entities. In the absence of well deﬁ  ned patho-
physiological factors at the cellular and molecular level, the clinical 
deﬁ  nition and classiﬁ  cation of depression has been structured in 
diagnostic tools such as the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) and the International Classiﬁ  cation of 
Diseases and Related Health Problems (ICD-10). This syndromatic 
approach relies in the clustering of core psychopathological phe-
nomena that characterize a depressive state. However, the assumed 
core symptoms, such as anhedonia and learned helplessness, are 
not speciﬁ  c, being often present in distinct psychiatric disorders 
such as bipolar disorder, obsessive compulsive disorder or even 
schizophrenia (Mathews et al., 2005).
The interesting overlap between the emotional changes observed 
in depression and anxiety disorders suggest a common psycho-
pathological pathway that may account for the high co-morbidity 
between mood and anxiety disorders (Hettema, 2008; Mergl et al., 
2007). Less marked, but equally relevant, are the cognitive changes 
observed in depression and anxiety disorders (Castaneda et al., 
2008), and the idea of a continuum between emotional changes and 
cognitive impairments has recently gained currency (Sotiropoulos 
et al., 2008; Swaab et al., 2005). Thus, the subjective separation of 
these three behavioral dimensions – depressive mood, anxiety and 
impaired cognition – while practical for diagnostic classiﬁ  cation 
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 quality,  intensity and duration. Paradigms involving chronic stress, 
such as the sustained social stress (Fuchs, 2005) or unpredictable 
chronic mild stress (uCMS) (Porsolt, 2000; Willner and Mitchell, 
2002), have produced the most consistent results in terms of anhe-
donia and learned helplessness, particularly in rats (D’Aquila et al., 
1994; Willner, 2005). Importantly, the stress-induced depressive-
like behavior that results from such treatments can be attenuated 
by various antidepressant drugs. Interestingly, independent studies 
have shown that chronic stress also triggers anxiety (Griebel et al., 
2002a,b) and cognitive impairments in spatial memory tasks (Song 
et al., 2006) and object recognition tasks (Orsetti et al., 2007), which 
in the case of the latter can be ameliorated by antidepressant treat-
ment (Elizalde et al., 2008). Despite the fact that anhedonic and 
learned helplessness responses to uCMS have been correlated in 
previous studies (Strekalova et al., 2004), we are unaware of any 
study designed to assess the interplay between mood, anxiety and 
cognition in the uCMS animal model of depression.
In this study, a depressive-like phenotype was induced in rats 
using an uCMS paradigm. Depressive-like behavior was conﬁ  rmed 
with the sucrose consumption test (SCT) and forced swimming test 
(FST), anxiety-related behavior was evaluated in the elevated-plus 
maze (EPM) and novelty suppressed feeding (NSF) paradigm, and 
learning and memory acquisition were tested using two different 
tasks in the Morris water maze (MWM). In addition, the therapeu-
tic effects of two different antidepressant drugs (ﬂ  uoxetine and imi-
pramine) on these three behavioral dimensions were evaluated.
MATERIALS AND METHODS
ANIMALS
Male Wistar rats (Charles-River Laboratories), weighing 300–400 g 
and aged 3 months were housed (three per cage) under standard 
laboratory conditions (12 h light: 12 h dark cycle, at 22°C, relative 
humidity of 55%; free access to food and water). Fifty-six animals 
were randomly assigned to four main experimental groups – a 
control group without stress exposure, treated with saline and three 
groups exposed to CMS and treated with either saline, ﬂ  uoxetine 
or imipramine (n = 14 per group). Animals were brought to the 
behavioral laboratory at least 1 h prior to testing and all experi-
mental sessions were conducted during the diurnal phase, between 
10:00 and 18:00 h. All procedures were carried out in accordance 
with European Union Directive 86/609/EEC and NIH guidelines 
on animal care and experimentation.
UNPREDICTABLE CHRONIC MILD STRESS
A slightly modiﬁ  ed version of an uCMS protocol (Willner, 2005) 
was used. It consisted of chronic exposure to unpredictable mild 
stressors (conﬁ  nement to a restricted space for 1 h, placement in a 
tilted cage (30°) for 3 h, housing on damp bedding for 8 h, over-
night illumination, 18 h food deprivation followed by exposure to 
inaccessible food for 1 h, water deprivation for 18 h followed by 
exposure to an empty bottle for 1 h, and reversed light/dark cycle 
for 48 h every 7 days) over a period of 6 weeks. During the last 
2 weeks of uCMS, animals were given daily injections of saline, 
ﬂ  uoxetine or imipramine.
All animals (controls and uCMS-exposed) were given a behav-
ioral test battery, as described below. Sucrose preference tests were 
performed weekly over the 6 weeks of exposure to uCMS. The 
rest of the tests (EPM, NSF, FST and two learning tasks in the 
MWM) were administered sequentially according to a design to 
avoid between-test interference effects (Elizalde et al., 2008; Võikar 
et al., 2001).
SUCROSE CONSUMPTION TEST
Anhedonia was assessed weekly during exposure to uCMS using 
the SCT. Brieﬂ  y, animals were allowed to habituate to the sucrose 
solution for 1 week before the uCMS protocol to establish base-
line preference levels. To test sucrose preference, animals that 
were food- and water-deprived for 18 h were presented with two 
pre-weighed bottles containing 1% sucrose solution or tap water 
for a period of 1 h. Sucrose preference was calculated according 
to the formula: sucrose preference  =  [sucrose intake/(sucrose 
intake + water intake)] × 100, as previously described (Bekris et al., 
2005). Anhedonia was deﬁ  ned as a reduction in sucrose preference 
relative to baseline levels.
ELEVATED-PLUS MAZE
The EPM was used to test anxiety-like behavior. The EPM appara-
tus was made of black polypropylene (ENV-560; MedAssociates), 
consisted of two opposite open arms (50.8 × 10.2 cm) and two 
enclosed arms (50.8  × 10.2 × 40.6 cm)  elevated  72.4 cm  above 
the ﬂ  oor. The junction area between the four arms measured 
10 × 10 cm. A raised edge (0.5 cm) on the open arms provided 
additional grip for the rats. Rats were placed individually in the 
center of the maze facing a closed arm and were allowed 5 min of 
free exploration. Behavioral parameters were recorded with the use 
of an infra-red photobeam system connected to a computer with 
speciﬁ  c software (MedPCIV, MedAssociates). After each trial, the 
maze was cleaned with 10% ethanol. The time spent in the open 
arms was used to calculate the percentage of time in the open 
arms which was taken as an index of anxiety-like behavior. The 
total number of entries in the closed arms was used as a measure 
of general locomotor activity.
NOVELTY SUPPRESSED FEEDING
Anxiety-like behavior was also assessed using the NSF paradigm. 
Following published protocols (Bodnoff et al., 1998), animals were 
food-deprived for 23 h before being placed in a novel environment 
for 10 min (an open-ﬁ  eld arena; MedAssociates Inc) where a single 
food pellet was centrally placed. Upon reaching the pellet, animals 
were returned to their home cages where they were presented with 
pre-weighed food over a period of 5 min. Latency to feeding in 
the open ﬁ  eld was used as an index of anxiety-like behavior; the 
amount of food consumed in the home cage provided a measure 
of appetitive drive.
FORCED SWIMMING TEST
Learned helplessness was evaluated in the FST on the last day of 
exposure to uCMS. Twenty-four hours after a pre-test session 
(10 min), rats were placed in cylinders ﬁ  lled with water (25°C; 
depth 30 cm) for a period of 5 min. Test sessions were assessed using 
a camera connected to a video tracking system (Viewpoint); the sys-
tem automatically calculated immobility time and latency to immo-
bility. Learned helplessness behavior was deﬁ  ned as an increase in 
time of immobility and a decrease in latency to immobility.Frontiers in Behavioral Neuroscience  www.frontiersin.org  January  2009 | Volume  3 | Article  1 | 3
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MORRIS WATER MAZE
An evaluation of cognitive function was performed in a spatial 
learning task (hippocampal-dependent) and a reverse learning 
task (prefrontal cortex-dependent) in the MWM (Cerqueira et al., 
2007a). The MWM apparatus consisted of a black tank (diameter: 
170 cm; depth: 50 cm), divided in quadrants by imaginary lines, 
and ﬁ  lled with water (22°C) to a depth of 31 cm. During testing, 
a black platform (12 × 12 cm; invisible to the rats) was placed at 
a height of 30 cm. The room was dimly lit and extrinsic visual 
clues were glued to the walls. Data were collected using a video-
tracking system (Viewpoint). In the spatial learning task, animals 
were tested for three consecutive days (four trials per day, with a 
maximum of 2 min per trial). The escape platform was placed in 
the centre of an arbitrarily-deﬁ  ned quadrant, assigned to a spe-
ciﬁ  c test subject. To avoid possible bias effects due to geographic 
preference, “animal-platform position” was paired between the 
different treatment groups. Test sessions begun with rats being 
placed, facing the wall of the maze, in a deﬁ  ned start position 
and ﬁ  nished once the escape platform had been reached. This 
procedure was continued in a clock-wise fashion over the sub-
sequent trials. The distance travelled and the time spent to reach 
the platform was recorded. When the escape platform was not 
reached within 2 min, the experimenter guided the animal to the 
platform. At the end of each test session, animals were dried and 
allowed to rest for 30 s before being returned to the maze for the 
remaining test sessions of that day. On the fourth day, animals were 
tested in a reverse learning task in which the escape platform was 
positioned in a new (opposite) quadrant and rats were tested in 
a four-trial paradigm, as described above. For this task, distance 
and time spent swimming in each quadrant were recorded. The 
difference between distances travelled in the quadrant containing 
the newly-positioned platform (“new”) and the quadrant that pre-
viously contained the platform (“old”) was calculated as a measure 
of reversal performance. The total distance swum was evaluated 
as a measure of locomotor activity.
DRUGS
The antidepressant drugs used were ﬂ  uoxetine  (10 mg/kg, 
Kemprotec) and imipramine (10 mg/kg, Sigma-Aldrich). Com-
pounds were dissolved in 5% DMSO in 0.9% saline. Fluoxetine, 
imipramine and vehicle (0.9% saline) were administered intraperi-
toneally (1 ml/kg) during the last 2 weeks of the uCMS protocol. 
All injections were performed at 20:00. The doses of antidepressant 
drugs administered daily were chosen based in their therapeutic 
effects in previous studies (Song et al., 2006).
STATISTICAL ANALYSIS
After conﬁ  rmation of homogeneity, appropriate statistical tests 
were applied to the data. Repeated measures ANOVA was used to 
analyze the results of the sucrose preference test and of the spatial 
learning task in the MWM. One-way ANOVA was used to evaluate 
the impact of uCMS and antidepressant treatment in the EPM, NSF, 
FST and reverse learning task in the MWM. Differences between 
groups were determined by post-hoc analysis, using Tukey’s honestly 
signiﬁ  cant difference test (Tukey HSD). Correlations between the 
different behavioral parameters were evaluated by the Pearson coef-
ﬁ  cient (r) test in which data from control and uCMS groups was 
included. Statistical signiﬁ  cance was accepted for P < 0.05. Results 
are expressed as mean ± s.e.m.
RESULTS
PARALLEL CHANGES IN MOOD, ANXIETY AND COGNITION AFTER uCMS 
AND ANTIDEPRESSANTS
Exposure to uCMS induced relevant changes in all three behav-
ioral domains studied. In the SCT, performed during the 6 weeks 
of the protocol, animals exposed to uCMS showed a signiﬁ  cantly 
decreased preference for sucrose when compared to control ani-
mals (F1,26 = 89.513, P < 0.001) (Figure 1A). This effect was sig-
niﬁ   cantly reversed by antidepressant treatment (F2,52 = 5.559, 
P = 0.006). Curiously, the tricyclic agent imipramine exhibited an 
earlier onset of antidepressant action; this drug reversed anhedonic 
behavior within the ﬁ  rst week of treatment (P < 0.001), whereas 
the responses to the SSRI ﬂ  uoxetine only appeared after 2 weeks 
(P < 0.001). Consistent with these data suggestive of a depressed 
phenotype, animals exposed to uCMS showed increased immo-
bility time (F1,26 = 37.568, P < 0.001) (Figure 1B) and decreased 
latency to immobility (F1,26 = 32.894, P < 0.001) in the FST (data 
not shown). Antidepressant treatment proved to be a signiﬁ  cant 
factor in recovery from learned helplessness as evaluated in the 
FST (F2,52 = 27.962, P < 0.001); when compared to stressed rats that 
did not receive drug treatments, immobility time was signiﬁ  cantly 
reduced by ﬂ  uoxetine (P < 0.001) and imipramine (P < 0.001) and 
the latency time to immobility was signiﬁ  cantly increased by both 
drugs (P < 0.001) (data not shown).
As compared to controls, animals exposed to uCMS spent sig-
niﬁ  cantly less time in the open arms of the EPM (F1,26 = 4.405, 
P = 0.046) (Figure 1C), but displayed no changes in locomotor 
activity (measured by the total number of closed arms entries) (data 
not shown). The performance in the EPM was not signiﬁ  cantly 
affected by antidepressant treatment (F2,52 = 0.630, P = 0.534). In the 
NSF test, stressed animals exhibited an increase in the latency time to 
feed (F1,26 = 6.177, P = 0.02) (Figure 1D), while food intake did not 
differ between control and uCMS-exposed rats (data not shown). A 
signiﬁ  cant effect of treatment was observed in the NSF (F2,52 = 2.517, 
P < 0.001), with P < 0.001 in animals treated with either ﬂ  uoxetine 
or imipramine vs. stressed animals receiving no drug treatment. 
Interestingly, imipramine in stressed animals proved to be anxiolytic 
in the NSF, when compared to control animals (P = 0.02). Neither 
antidepressant altered food intake in the NSF (data not shown).
Evaluation of spatial learning in the MWM failed to reveal 
any signiﬁ  cant differences between controls and uCMS animals 
(Figure 2A). Accordingly, neither imipramine nor ﬂ  uoxetine 
induced changes in performance in the spatial learning task in 
the MWM. On the other hand, performance in the reverse learn-
ing task was signiﬁ  cantly impaired in animals exposed to uCMS 
(Figure 2B), indicated by the lower percentage of distance swum in 
the “new” quadrant to which the platform had been re-positioned 
(F1,26 = 13.427, P = 0.001), as opposed to an higher percentage spent 
in the “old” quadrant containing the platform during training ses-
sions (F1,26 = 12.716, P = 0.001). This impairment in reverse learning 
was reversed by antidepressant treatment (F2,52 = 4.476, P = 0.016, 
for the percentage of distance swum in quadrant containing the 
re-positioned platform and F2,52 = 9.021, P < 0.001 in the quad-
rant containing the platform during training sessions). Animals Frontiers in Behavioral Neuroscience  www.frontiersin.org  January  2009 | Volume  3 | Article  1 | 4
Bessa et al.  Behavioral correlations in a model of depression
FIGURE 1 | Behavioral effects of uCMS and antidepressant treatment on mood and anxiety domains. (A) Sucrose preference in the SCTs performed during 
uCMS. (B) Immobility time in the FST, (C) percentage of time spent in the open arms of the EPM and (D) latency time to feed in the NSF paradigm. *P < 0.005. Data 
presented as mean ± s.e.m.
FIGURE 2 | Behavioral effects of antidepressants in the cognitive performance in the Morris watermaze. (A) Average distance swum in the spatial learning 
task and (B) the percentage of distance swum in each quadrant in the reverse learning task in the Morris watermaze. *P < 0.005. Data presented as
mean ± s.em.Frontiers in Behavioral Neuroscience  www.frontiersin.org  January  2009 | Volume  3 | Article  1 | 5
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treated with ﬂ  uoxetine and imipramine travelled signiﬁ  cantly lower 
distances in the “old” quadrant (P = 0.003 for both) and longer 
distances in the “new” quadrant (P = 0.046 and P = 0.038, respec-
tively). Locomotor activity measured by the total distance swum 
was not altered by exposure to stress or  treatment with antidepres-
sants, conﬁ  rming the results observed in the EPM.
INTERPLAY BETWEEN STRESS-INDUCED CHANGES IN MOOD, ANXIETY 
AND COGNITION
Intra-domain correlation analysis revealed a negative correla-
tion between sucrose preference and immobility time in the FST 
(r = −0.751 (26), P < 0.001), conﬁ  rming that animals with lower 
preference for sucrose were immobile for longer in the FST. In con-
trast, no signiﬁ  cant correlation was found between the measures of 
anxiety in the EPM and NSF, or the measures of cognition in the two 
versions of the MWM (spatial learning and reversal learning).
Correlation analysis was also performed to inspect for synergis-
tic inter-domain effects as represented in Figure 3. Analyzing the 
interactions between mood and anxiety revealed a negative correla-
tion between sucrose preference and latency of time to feed in the 
NSF [r = −0.397 (26), P = 0.036]; in addition, a positive correlation 
between immobility time in the FST and latency of time to feed in 
the NSF [r = 0.458 (26), P = 0.014] was found. On the other hand, 
we failed to ﬁ  nd signiﬁ  cant correlations between parameters of 
mood and percentage of time in the open arms of the EPM. With 
respect to interactions between mood and cognition, we observed 
a positive correlation between sucrose preference and performance 
in the reverse learning task [r = 0.695 (26), P < 0.001]; moreover, 
a negative correlation was found between immobility time in the 
FST and performance (in the reverse learning task [r = −0.561 (26), 
P = 0.002]. Finally, an interplay between anxiety and cognition was 
demonstrated by the negative correlation between the latency of 
time to feed in the NSF and the performance in the reverse learning 
task [r = −0.404 (26), P = 0.033].
DISCUSSION
This study used a multidimensional analysis of the behavioral 
responses to uCMS to examine the relevance of commonly used 
measures in this animal model of human depression. Etiological 
validity of the model is provided by the fact that stress is an 
important precipitating event both in the animal model and in 
clinical depression (Willner and Mitchell, 2002). Thus, the use of 
uCMS to model depressive-like behavior is justiﬁ  ed. In addition, 
construct validity is conferred to the model by the fact that the 
neurobiological processes triggered by stress are similar in ani-
mals and humans (Anisman and Matheson, 2005; Steckler, 2001). 
Nevertheless, the uCMS model of depression has remained poorly 
characterized in terms of the similarities with the symptom proﬁ  le 
of clinical depression, namely in its anxiety and cognitive dimen-
sions (Willner, 2005). By demonstrating signiﬁ  cant inter-domain 
behavioral interactions, the present work adds signiﬁ  cantly to the 
face validity of the uCMS model of depression.
Our results conﬁ  rm previous observations (Bekris et al., 2005; 
D’Aquila et al., 1994; Silva et al., 2008; Willner et al., 1996) that 
exposure to uCMS induces signiﬁ  cant changes in mood-related 
behavior, characterized by an anhedonic state with decreased sucrose 
preference and increased immobility in the FST. Furthermore, the 
signiﬁ  cant negative correlation observed between these two meas-
ures implies that the most anhedonic animals are the most helpless 
in the FST. This demonstration further strengthens the view that 
anhedonia and learned helplessness are core symptoms of depres-
sive behavior.
The effect of uCMS in anxiety-related behavior has been a 
matter of recent debate (Kompagne et al., 2008), with reports of 
decreased (D’Aquila et al., 1994; Kopp et al., 1999) and increased 
(Griebel et al., 2002a,b; Maslova et al., 2002) anxiety-like behavior 
in the EPM test after uCMS. In the present study, animals exposed 
to uCMS displayed marginally signiﬁ  cant decreases in the per-
centage of time spent in the open arms of the EPM, suggesting 
the induction of a mildly anxious phenotype. To overcome this 
lack of reproducibility in the EPM, we evaluated the impact of 
uCMS in another paradigm of anxiety-related behavior – the NSF 
paradigm (Bodnoff et al., 1998). Stress-induced anxiogenesis was 
conﬁ  rmed in the NSF by the observation of a signiﬁ  cant increase 
in the latency time to feeding. Since the results of the two tests of 
anxiety behavior (EPM and NSF) were not correlated, it would 
appear that each of these tests measures a distinct aspect of anxiety. 
In this respect, it should be noted that although both the EPM and 
FIGURE 3 | Inter-domain correlations between mood, anxiety and cognition. (A) Table shows Pearson correlation coefﬁ  cients between different behavioral 
parameters and (B) graphical representation of the correlations between mood (sucrose   preference), anxiety (latency to feed) and cognition (new–old quadrant 
distances).Frontiers in Behavioral Neuroscience  www.frontiersin.org  January  2009 | Volume  3 | Article  1 | 6
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NSF are conﬂ  ict-based tests (Sousa et al., 2006), performance in the 
EPM depends strongly on exploratory behavior, contrasting with 
behavior in the NSF which depends on appetitive drive because 
of the necessity of food deprivation. Accordingly, behavior in the 
EPM may be more sensitive to minor differences in environmental 
stimuli, possibly accounting for the disparate reports on the effects 
of uCMS.
Several studies have described uCMS-induced changes in cog-
nitive function. For example, mice subjected to the uCMS para-
digm show impairments in recognition memory (Elizalde et al., 
2008; Li et al., 2008) as well as in spatial learning and memory 
(Song et al., 2006). Our study failed to observe performance dif-
ferences between stressed and control rats in a spatial learning task 
in the MWM. However, those animals exposed to uCMS displayed 
marked cognitive impairments when tested in a reverse learning 
task. Dissociation in cognitive performance in the different tasks 
may be suggestive of the greater vulnerability of the prefrontal 
cortex (a brain region implicated in reverse learning; Cerqueira 
et al., 2007a,b) to the deleterious effects of uCMS, as compared to 
the hippocampus (which is primarily involved in spatial learning 
tasks). Supporting this interpretation, the analysis revealed poor 
correlation between performances on the two tasks.
A primary aim of this study was to assess the complex interactions 
between mood, anxiety and cognition. Previous studies reported 
correlations between immobility time in the FST and performance 
in an object recognition task (Elizalde et al., 2008) and between 
sucrose preference and performance in a social avoidance test 
(Kompagne et al., 2008). Analysis of data collected in the present 
study revealed a strong correlation between the two core symptoms 
of depressive behavior – anhedonia and learned helplessness – and 
both, the anxious phenotype (measured in the NSF) and cognitive 
impairments (reverse learning task). Furthermore, a signiﬁ  cant cor-
relation emerged between anxiety-related behavior in the NSF and 
cognitive performance in the reverse learning task. These results 
therefore show that the three different behavioral dimensions ana-
lyzed are likely to be interdependent, with each contributing to the 
dynamic processes that underlie depressive behavior.
The issue of whether the uCMS paradigm represents a valid 
model of depression was addressed by analyzing the ability of anti-
depressant drugs to ameliorate the various uCMS-induced changes 
in behavior (predictive validity). Consistent with previous work 
(Griebel et al., 2002a; Song et al., 2006), the present experiments 
demonstrated the efﬁ  cacy of tricyclic agents (e.g. imipramine) and 
selective serotonin reuptake inhibitors (SSRI; e.g. ﬂ  uoxetine) in 
reversing the anhedonic and helpless behaviors that develop after 
exposure to uCMS. Interestingly, imipramine showed a faster onset 
of action (with 1 week) as compared to ﬂ  uoxetine whose ﬁ  rst effects 
were observed only after 2 weeks; these different temporal proﬁ  les 
most likely reﬂ  ect the dosages used, different mechanisms of drug 
action and/or neurochemical substrates.
The anxiolytic actions of antidepressant drugs have been exten-
sively demonstrated in the NSF paradigm in stress-naive animals 
(Bodnoff et al., 1989) as well as in transgenic models of depressive 
behavior, e.g. the serotonin transporter (SERT) knockout rat (Olivier 
et al., 2008). In the present study, we found that both ﬂ  uoxetine and 
imipramine displayed anxiolytic properties when uCMS-exposed rats 
were tested in the NSF, but not in the EPM. These ﬁ  ndings reinforce 
the view that the EPM, although considered to be the gold standard in 
the development of novel anxiolytic agents (Dawson and Tricklebank, 
1995), may lack the desired sensitivity and reproducibility in stress 
exposure models and chronic antidepressant treatment.
Finally, our results clearly revealed that imipramine and ﬂ  uox-
etine attenuate uCMS-induced impairments in cognitive perform-
ance, as measured by the reverse learning task in the MWM. These 
ﬁ  ndings concur with those of a previous study that reported partial 
reversal by the SSRI paroxetine of stress-induced impairment in 
an object recognition task (Elizalde et al., 2008), as well as those 
of a recent clinical study that suggested the use of antidepressants 
for improving prefrontal cortex-dependent cognitive functions in 
patients with recurrent depression (Borkowska et al., 2007).
In summary, the results of this study show that depression-like 
behavior, anxiety and impaired cognition as three highly inter-
dependent variables that act in overlapping and synergistic modes; 
from a broader viewpoint, our results also show that there is a 
continuum between emotional changes and cognitive impairments. 
Further, these results demonstrate interactions between different 
behavioral domains that crosscut the disciplines of psychiatry and 
neurology.
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